
Phage Therapy - Part A
- 1st Edition, Volume 200 - September 18, 2023
- Latest edition
- Editor: Vijai Singh
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 5 6 3 - 8
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 5 6 4 - 5
Phage Therapy - Part A, Volume 200 is an informative text on phage and their use for treatment in bacterial infections. The book highlights a number of aspects of the phage in… Read more

Phage Therapy - Part A, Volume 200 is an informative text on phage and their use for treatment in bacterial infections. The book highlights a number of aspects of the phage in a way that can help students, researchers, clinicians, entrepreneurs and stakeholders perform their research with great interest. Chapters in this new release cover An introduction to bacteriophage and their therapeutic applications, Isolation, screening and characterization of phage, Synthetic phage and their application in phage therapy, Phage engineering for development of diagnostic tools, Phage design and directed evolution to evolve phage for therapy, and more.
Additional sections cover Host-phage interactions and modelling for therapy, Phage and phage cocktails formulations, Phage for treatment of Escherichia coli infection, Phage for treatment of Klebsiella pneumoniae infection, Phage for treatment of Salmonella spp infection, Phage for treatment of Staphylococcus aureus infection, and Phages for treatment of Acinetobacter baumannii infection.
- Includes discussions on phage isolation, screening and characterization
- Covers synthetic phage, phage for diagnostic, directed evolution and host interaction
- Presents the latest on phage for treatment of bacterial infections
Basic researchers, Clinicians, Pharmacologists, students
PrefaceVijai Singh1. Exploring the potential of phage and their applicationsKhushal Khambhati, Gargi Bhattacharjee, Nisarg Gohil, Rupesh Maurya, and Vijai Singh2. Isolation, screening and characterization of phageBishoy Maher Zaki, Amira A. Mohamed, Alyaa Dawoud, Kareem Essam, Zainab K. Hammouda, Abdallah S. Abdelsattar, and Ayman El-Shibiny3. Synthetic phage and its application in phage therapyAjay Kumar and Anuj Yadav4. Phage engineering for development of Diagnostic toolsSubha Sankar Paul5. Phage design and directed evolution to evolve phage for therapyPriyancka Arora, Avni Jain, and Ajay Kumar6. Host-phage interactions and modelling for therapyJoshua Williams, Nathan Burton, Gurneet Dhanoa, and Antonia P. Sagona7. Phage and phage cocktails formulationsIndra Mani8. Phages for treatment of Escherichia coli infectionsNikita Nikulin, Alexandra Nikulina, Andrei Zimin, and Rustam Aminov9. Phages for Treatment of Klebsiella pneumoniae InfectionsBishoy Maher Zaki, Assmaa H. Hussein, Toka A. Hakim, Mohamed S. Fayez, and Ayman El-Shibiny10. Phages for treatment of Salmonella spp infectionV. Baskaran and L. Karthik11. Phages for Treatment of Staphylococcus aureus InfectionSafia Samir12. Phages for treatment of Acinetobacter baumannii infectionRamneet Kaur, Dibita Mandal, and Ajay Kumar
- Edition: 1
- Latest edition
- Volume: 200
- Published: September 18, 2023
- Language: English
VS
Vijai Singh
Prof. Vijai Singh is currently serving as Head of the Department of Biosciences, School of Science and Dean (Research & Innovation) at Indrashil University, Rajpur, Mehsana, India. Prior to this, he held the position of Associate Professor in the same department at Indrashil University. He has also served as Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, and in the Department of Biotechnology at the Invertis University, Bareilly, India. Earlier of his career, Prof. Singh worked as a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and at the School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He earned his Ph.D. in Biotechnology in 2009 from the ICAR-National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India. His doctoral research focused on the development of molecular and immunoassays for the diagnosis of Aeromonas hydrophila. Prof. Singh’s research interests lies in the design and construction of novel biosynthetic pathways for production of medically and industrially important biomolecules. His laboratory is also actively engaged in developing CRISPR-Cas systems for gene knock out, knock in, gene regulation and diagnostic. With over 15 years of research and teaching experience, his areas of expertise include synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has an extensive academic record, with over 110 articles, 89 book chapters, 26 books and 3 patents to his credits. Prof. Singh has received number of prestigious awards, including the Bioclues Innovation, Research and Development Award (2023) from the BIOCLUES Society, the Vice Chancellor's Best Research Award (2023) from Indrashil University, and the Agathiyar Chemical Biology Award (2023) from the Society of Chemical and Synthetic Biology. At Indrashil University, he currently serves as chairman of the Board of Study, and is a member of the Academic Council of Indrashil University. He also holds the position of the Member Secretary of the Institutional Biosafety Committee (IBSC) at the university. Dr. Singh is actively involved in national and international scientific advisory roles.